States are outraged at the fact that they are going to be paying higher prices for coronavirus vaccines than the Centre.
The Centre has paid Rs 150 per dose, both for the AstraZeneca vaccine, Covishield, manufactured by the Serum Institute of India and Bharat Biotech’s Covaxin. “Our price remains the same as earlier,” a government official told Business Standard.
But for future contracts with state governments, who will lead the vaccination campaign for those below 45, the Serum Institute has quoted a price tag of Rs 400 per dose, effectively 166 per cent more than what the Centre has paid till now. Bharat Biotech has not declared the price that Covaxin will demand on future contracts.